Non-Invasive Prenatal Testing (NIPT) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Non-Invasive Prenatal Testing (NIPT) Market was valued at approximately USD 1,490 million in 2020 and it is expected to reach USD 3,396 million by 2027, registering a CAGR of nearly 14% during the forecast period (2021-2027).

Non-invasive prenatal testing (NIPT), also known as cell-free DNA testing, is considered an important addition to the range of screening tests available for fetal chromosomal abnormalities. NIPT is considered superior to other screening tests, especially for trisomy 21 (one of the most common chromosomal abnormalities). Prenatal screening for fetal chromosomal abnormalities is done for people who want to test for fetal chromosomal abnormalities or are at high risk of fetal chromosomal abnormalities. NIPT allows individuals to make an informed decision about whether to proceed with diagnostic testing. Serious fetal chromosomal abnormalities usually involve the gain or loss of genetic material from a small portion of a chromosome to an entire chromosome. Typically, NIPT is performed through methods such as ultrasound detection, biochemical screening tests, and cell-free DNA in the Maternal Plasma Test.

Market Segments

By Product

• Products
• Consumables
• Assay Kits & Reagents
• Disposables
• Instruments
• NGS Systems
• PCR Instruments
• Microarrays
• Ultrasound Devices

By Method

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Tests

Key Players

• Ariosa Diagnostics, Inc.
• Berry Genomics Co. Ltd.
• BGI Diagnostics 
• Illumina, Inc.
• LifeCodexx AG
• Natera, Inc.
• Sequenom Laboratories
• Quest Diagnostics, Inc.

Scope of the Report

The research study analyzes the global Non-Invasive Prenatal Testing (NIPT) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Non-Invasive Prenatal Testing (NIPT) Market Report

1. What was the Non-Invasive Prenatal Testing (NIPT) Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Non-Invasive Prenatal Testing (NIPT) Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Non-Invasive Prenatal Testing (NIPT) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.